Novartis stock pre-market at EUR 128.74
Published on 10/13/2026 at 08:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Novartis stock was at EUR 128.74 pre-market at Lang & Schwarz on October 13, 2026.
- The bid was EUR 128.48 and the ask was EUR 129.00.
- Novartis has scheduled its third-quarter 2026 results for October 27, 2026.
Novartis stock was at EUR 128.74 pre-market at Lang & Schwarz on October 13, 2026, at 8:16 a.m. CEST. The bid was EUR 128.48 and the ask was EUR 129.00.
What matters today
The next scheduled financial-results date is October 27, 2026, when Novartis is due to report third-quarter results. EUR 130.00 is the next round-number level, 0.98 percent above the pre-market price. A structured quote dated October 12, 2026, lists a price-to-earnings ratio of 21.99 and a trailing dividend yield of 3.00 percent.
The company’s investor-relations calendar identifies October 27, 2026, as the date for its online financial-results presentation for the third quarter of 2026. Novartis’ latest investor-relations materials also list its second-quarter 2026 results, released on July 21, 2026. Novartis investor relations identifies the company’s financial calendar and reporting materials.
The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Novartis stock.
Market context: Market report SMI.
